Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Jan 24.

Published in final edited form as: Biol Blood Marrow Transplant. 2014 Apr 24;20(9):1307–1313. doi: 10.1016/j.bbmt.2014.04.018

Table 1. Patient features.

		n (%)
Total patients		29
Recipient gender, M/F		16/13
Age, median (range)		34 (16 – 67)
Subtype	B-ALL	29 (100)
Risk feature	Ph+	11 (38)
Status at HCT	CR1	12 (41)
	CR2	9 (31)
	CR3	2 (6.9)
	Relapse/Refractory	6 (21)
Regimen	Ablative	24 (83)
	Non-myeloablative	5 (17)
Graft	PBSC	24 (83)
	BM	5 (17)
Donor	Matched sibling	17 (59)
	Matched unrelated	10 (34)
	Haploidentical	2 (6)
Status at last f/u	Alive	7 (24)
	Dead	22 (76)
DFS, days, median (range)		252 (74 – 3110)
OS, days, median (range)		572 (85 – 3110)

BM=bone marrow; CR=complete remission; DFS=disease-free survival; PBSC=peripheral blood stem cells; OS=overall survival